REPL
NASDAQ HealthcareReplimune Group, Inc. - Common Stock
Biotechnology
📊 Market Data
| Price | $7.58 |
|---|---|
| Volume | 1,120,659 |
| Market Cap | 625.90M |
| Beta | 0.770 |
| RSI (14-Day) | 38.0 |
| 200-Day MA | $7.77 |
| 50-Day MA | $7.85 |
| 52-Week High | $13.24 |
| 52-Week Low | $2.68 |
| Forward P/E | -3.78 |
| Price / Book | 2.87 |
🎯 Investment Strategy Scores
How REPL scores across each investment strategy. Higher is better for that strategy's goals.
💰 Dividend Daddy
39/100
High dividend yield + low volatility
🚀 Moon Shot
40/100
High growth potential (high beta + oversold)
🔪 Falling Knife
50/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
49/100
Overbought stocks (potential short candidates)
🐋 Institutional Whale
17/100
Large-cap, institutional-quality stocks
Find REPL in your text
Paste any text on the homepage — the tool will extract REPL and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.